SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Rogers, M. P.
Right arrow Articles by Liang, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rogers, M. P.
Right arrow Articles by Liang, M. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

I-123 Iofetamine SPECT Scan in Systemic Lupus Erythematosus Patients with Cognitive and Other Minor Neuropsychiatric Symptoms: A Pilot Study

Malcolm P. Rogers

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Elizabeth Waterhouse

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

James S. Nagel

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Neal W. Roberts

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Steven H. Stern

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Patricia Fraser

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Robert Partridge

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Benjamin Murawski

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Shahram Khoshbin

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

B. Leonard Holman

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Peter H. Schur

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Matthew H. Liang

Divisions of Psychiatry and Neurology, Departments of Medicine, Rheumatology and Immunology, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Robert B. Brigham Multipurpose Arthritis Center, Boston, Massachusetts, USA

Accurate diagnosis of central nervous system (CNS) lupus remains difficult, especially when the manifestations are of subtle cognitive and affective changes. This pilot study reports on the use of I-123 iofetamine single photon emission computerized tomography (SPECT) scans in 18 such patients with documented systemic lupus erythematosus. Eight of the 18 scans were abnormal (44%), four in a diffuse bitemporo-parietal pattern previously noted only in Alzheimer's disease, and four with large focal deficits. Neither the existence of the abnormal scan nor the particular pattern of abnormality correlated with the results of other diagnostic tests. These preliminary results raise the possibility that SPECT scans may offer an additional valuable diagnostic instrument in CNS lupus, although further studies are necessary to delineate their precise role.

Key Words: Lupus • SLE • SPECT • Neuropsychiatric • Cognitive

Lupus, Vol. 1, No. 4, 215-219 (1992)
DOI: 10.1177/096120339200100404


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
G Castellino, M Govoni, M Padovan, P Colamussi, M Borrelli, and F Trotta
Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up
Ann Rheum Dis, July 1, 2005; 64(7): 1022 - 1027.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
M Govoni, G Castellino, M Padovan, M Borrelli, and F Trotta
Recent advances and future perspective in neuroimaging in neuropsychiatric systemic lupus erythematosus
Lupus, March 1, 2004; 13(3): 149 - 158.
[Abstract] [PDF]


Home page
LupusHome page
F J Lopez-Longo, N Caro, M I Almoguera, J Olazaran, J C Alonso-Farto, A Ortega, I Monteagudo, C M. Gonzalez, and L Carreno
Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage
Lupus, November 1, 2003; 12(11): 813 - 819.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
K. Oku, T. Atsumi, S. Furukawa, T. Horita, Y. Sakai, S. Jodo, Y. Amasaki, K. Ichikawa, O. Amengual, and T. Koike
Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvement
Rheumatology, June 1, 2003; 42(6): 773 - 777.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
F. Nobili, G. Rodriguez, A. Arrigo, B. Stubinski, E. Rossi, R. Cerri, E. Damasio, G. Rosadini, and A. Marmont
Accuracy of 133-xenon regional cerebral blood flow and quantitative electroencephalography in systemic lupus erythematosus
Lupus, April 1, 1996; 5(2): 93 - 102.
[Abstract] [PDF]



Advertisement